Latest debt-to-equity ratio
Adaptive Biotechnologies Debt-to-equity ratio
Direct answer
Adaptive Biotechnologies's debt-to-equity ratio is 272.46%.
The verified market snapshot reports 272.46%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 10, 2026.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 272.46%
Explore related company data
View Adaptive Biotechnologies's market capitalizationView Adaptive Biotechnologies's price-to-book ratioView Adaptive Biotechnologies's return on equityView Adaptive Biotechnologies's dividend yieldView Adaptive Biotechnologies's 52-week price rangeView Adaptive Biotechnologies's revenue growthView Adaptive Biotechnologies's profit marginView all Adaptive Biotechnologies key metricsReturn to Adaptive Biotechnologies profile